GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Trajan Group Holdings Ltd (OTCPK:TRJNF) » Definitions » EV-to-Revenue

TRJNF (Trajan Group Holdings) EV-to-Revenue : 1.07 (As of May. 29, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Trajan Group Holdings EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Trajan Group Holdings's enterprise value is $110.9 Mil. Trajan Group Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was $103.5 Mil. Therefore, Trajan Group Holdings's EV-to-Revenue for today is 1.07.

The historical rank and industry rank for Trajan Group Holdings's EV-to-Revenue or its related term are showing as below:

TRJNF' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.68   Med: 1.44   Max: 3.46
Current: 1.08

During the past 4 years, the highest EV-to-Revenue of Trajan Group Holdings was 3.46. The lowest was 0.68. And the median was 1.44.

TRJNF's EV-to-Revenue is ranked better than
82.02% of 823 companies
in the Medical Devices & Instruments industry
Industry Median: 3.1 vs TRJNF: 1.08

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-05-29), Trajan Group Holdings's stock price is $0.58. Trajan Group Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was $0.68. Therefore, Trajan Group Holdings's PS Ratio for today is 0.85.

Trajan Group Holdings EV-to-Revenue Historical Data

The historical data trend for Trajan Group Holdings's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trajan Group Holdings EV-to-Revenue Chart

Trajan Group Holdings Annual Data
Trend Jun21 Jun22 Jun23 Jun24
EV-to-Revenue
- 3.27 2.01 1.30

Trajan Group Holdings Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only - 2.01 - 1.30 -

Competitive Comparison of Trajan Group Holdings's EV-to-Revenue

For the Medical Instruments & Supplies subindustry, Trajan Group Holdings's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Trajan Group Holdings's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Trajan Group Holdings's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Trajan Group Holdings's EV-to-Revenue falls into.


;
;

Trajan Group Holdings EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Trajan Group Holdings's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=110.861/103.501
=1.07

Trajan Group Holdings's current Enterprise Value is $110.9 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Trajan Group Holdings's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 was $103.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Trajan Group Holdings  (OTCPK:TRJNF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Trajan Group Holdings's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.58/0.68
=0.85

Trajan Group Holdings's share price for today is $0.58.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2024 was $0.68.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Trajan Group Holdings EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Trajan Group Holdings's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Trajan Group Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Trajan Group Holdings Ltd (OTCPK:TRJNF) » Definitions » EV-to-Revenue
Comparable Companies
ASX:AHC ASX:SDI ASX:OSX ISRG XPAR:EL BDX TSE:7741 XSWX:ALC RMD TSE:4543 OCSE:COLO B XPAR:DIM XSWX:STMN COO BAX WST NZSE:FPH ALGN SOLV HOLX
Traded in Other Exchanges
Z0M:Germany TRJ:Australia
Address
7 Argent Place, Ringwood, VIC, AUS, 3134
Website
https://www.trajanscimed.com
Trajan Group Holdings Ltd is a developer and manufacturer of analytical and life sciences products and devices, seeking to enrich human well-being through scientific measurement. Its current portfolio of products comprises products, devices and solutions that are used in the analysis of biological, food, and environmental sample. The Group now reports in three operating segments: Components and Consumables, Capital Equipment and Disruptive Technologies. Key revenue is generated from Components and Consumables that includes parts, supplies, components and consumable products across the world. The Group operates in Asia (Malaysia, Japan and Australia and New Zealand (ANZ)), USA and Europe, Middle East, Africa, and India (EMEA).